{
  "DOI": "10.1186/s40246-015-0024-4",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-015-0024-4",
  "alternative-id": [
    "24"
  ],
  "article-number": "2",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "28 November 2014"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "18 January 2015"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "8 February 2015"
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Liu",
      "given": "Suqin",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Hongjiang",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Lizhi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tang",
      "given": "Chuanning",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jones",
      "given": "Lindsey",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ye",
      "given": "Hua",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ban",
      "given": "Liying",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Aman",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Liu",
      "given": "Zhiyuan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lou",
      "given": "Feng",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Dandan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sun",
      "given": "Hong",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dong",
      "given": "Haichao",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Guangchun",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dong",
      "given": "Zhishou",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guo",
      "given": "Baishuai",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yan",
      "given": "He",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yan",
      "given": "Chaowei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Lu",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Su",
      "given": "Ziyi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Li",
      "given": "Yangyang",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Huang",
      "given": "Xue F",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chen",
      "given": "Si-Yi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhou",
      "given": "Tao",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2015,
        2,
        7
      ]
    ],
    "date-time": "2015-02-07T06:53:31Z",
    "timestamp": 1423292011000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        9,
        2
      ]
    ],
    "date-time": "2021-09-02T07:53:45Z",
    "timestamp": 1630569225000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        10
      ]
    ],
    "date-time": "2024-02-10T15:26:17Z",
    "timestamp": 1707578777459
  },
  "is-referenced-by-count": 32,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2015,
        2,
        8
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2015,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2015,
            2,
            8
          ]
        ],
        "date-time": "2015-02-08T00:00:00Z",
        "timestamp": 1423353600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-015-0024-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-015-0024-4/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-015-0024-4",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-015-0024-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2015,
        2,
        8
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2015,
        2,
        8
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2015,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "J Ferlay",
      "key": "24_CR1",
      "unstructured": "Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 9/10/2014.",
      "volume-title": "GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]",
      "year": "2013"
    },
    {
      "DOI": "10.5888/pcd10.130136",
      "author": "B Wang",
      "doi-asserted-by": "publisher",
      "first-page": "E183",
      "journal-title": "Prev Chronic Dis.",
      "key": "24_CR2",
      "unstructured": "Wang B, He M, Wang L, Engelgau MM, Zhao W, Wang L. Breast cancer screening among adult women in China, 2010. Prev Chronic Dis. 2013;10:E183.",
      "volume": "10",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.fshw.2013.08.002",
      "author": "F-J He",
      "doi-asserted-by": "publisher",
      "first-page": "146",
      "journal-title": "Food Sci Hum Wellness.",
      "key": "24_CR3",
      "unstructured": "He F-J, Chen J-Q. Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: differences between Chinese women and women in Western countries and possible mechanisms. Food Sci Hum Wellness. 2013;2:146–61.",
      "volume": "2",
      "year": "2013"
    },
    {
      "DOI": "10.1002/cncr.22656",
      "author": "JG Brody",
      "doi-asserted-by": "publisher",
      "first-page": "2627",
      "journal-title": "Cancer.",
      "key": "24_CR4",
      "unstructured": "Brody JG, Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR, et al. Environmental pollutants, diet, physical activity, body size, and breast cancer. Cancer. 2007;109:2627–34.",
      "volume": "109",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S1470-2045(13)70567-9",
      "author": "L Fan",
      "doi-asserted-by": "publisher",
      "first-page": "e279",
      "journal-title": "Lancet Oncol.",
      "key": "24_CR5",
      "unstructured": "Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, et al. Breast cancer in China. Lancet Oncol. 2014;15:e279–289.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1155/2014/469251",
      "author": "CA Parise",
      "doi-asserted-by": "crossref",
      "first-page": "469251",
      "journal-title": "J Cancer Epidemiol.",
      "key": "24_CR6",
      "unstructured": "Parise CA, Caggiano V. Breast cancer survival defined by the ER/PR/HER2 subtypes and a surrogate classification according to tumor grade and immunohistochemical biomarkers. J Cancer Epidemiol. 2014;2014:469251.",
      "volume": "2014",
      "year": "2014"
    },
    {
      "DOI": "10.1038/35021093",
      "author": "CM Perou",
      "doi-asserted-by": "publisher",
      "first-page": "747",
      "journal-title": "Nature.",
      "key": "24_CR7",
      "unstructured": "Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–52.",
      "volume": "406",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.ctrv.2014.03.004",
      "author": "EM Ciruelos Gil",
      "doi-asserted-by": "publisher",
      "first-page": "862",
      "journal-title": "Cancer Treat Rev.",
      "key": "24_CR8",
      "unstructured": "Ciruelos Gil EM. Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer. Cancer Treat Rev. 2014;40:862–71.",
      "volume": "40",
      "year": "2014"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-09-1823",
      "author": "SR Johnston",
      "doi-asserted-by": "publisher",
      "first-page": "1979",
      "journal-title": "Clin Cancer Res.",
      "key": "24_CR9",
      "unstructured": "Johnston SR. New strategies in estrogen receptor-positive breast cancer. Clin Cancer Res. 2010;16:1979–87.",
      "volume": "16",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2013.54.1870",
      "author": "F Ades",
      "doi-asserted-by": "publisher",
      "first-page": "2794",
      "journal-title": "J Clin Oncol.",
      "key": "24_CR10",
      "unstructured": "Ades F, Zardavas D, Bozovic-Spasojevic I, Pugliano L, Fumagalli D, de Azambuja E, et al. Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. J Clin Oncol. 2014;32:2794–803.",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.3892/br.2013.187",
      "author": "MH Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "41",
      "journal-title": "Biomed Rep.",
      "key": "24_CR11",
      "unstructured": "Zhang MH, Man HT, Zhao XD, Dong N, Ma SL. Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (review). Biomed Rep. 2014;2:41–52.",
      "volume": "2",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nrclinonc.2013.124",
      "author": "M Ignatiadis",
      "doi-asserted-by": "publisher",
      "first-page": "494",
      "journal-title": "Nat Rev Clin Oncol.",
      "key": "24_CR12",
      "unstructured": "Ignatiadis M, Sotiriou C. Luminal breast cancer: from biology to treatment. Nat Rev Clin Oncol. 2013;10:494–506.",
      "volume": "10",
      "year": "2013"
    },
    {
      "DOI": "10.1002/cncr.28914",
      "author": "VG Abramson",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "journal-title": "Cancer.",
      "key": "24_CR13",
      "unstructured": "Abramson VG, Lehmann BD, Ballinger TJ, Pietenpol JA. Subtyping of triple-negative breast cancer: implications for therapy. Cancer. 2015;121:8–16.",
      "volume": "121",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.3798106",
      "author": "DJ Slamon",
      "doi-asserted-by": "publisher",
      "first-page": "177",
      "journal-title": "Science.",
      "key": "24_CR14",
      "unstructured": "Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235:177–82.",
      "volume": "235",
      "year": "1987"
    },
    {
      "DOI": "10.1056/NEJMra012284",
      "author": "R Wooster",
      "doi-asserted-by": "publisher",
      "first-page": "2339",
      "journal-title": "N Engl J Med.",
      "key": "24_CR15",
      "unstructured": "Wooster R, Weber BL. Breast and ovarian cancer. N Engl J Med. 2003;348:2339–47.",
      "volume": "348",
      "year": "2003"
    },
    {
      "DOI": "10.1146/annurev.pathol.4.110807.092311",
      "author": "N Chalhoub",
      "doi-asserted-by": "publisher",
      "first-page": "127",
      "journal-title": "Annu Rev Pathol.",
      "key": "24_CR16",
      "unstructured": "Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009;4:127–50.",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.onc.1208304",
      "author": "JW Lee",
      "doi-asserted-by": "publisher",
      "first-page": "1477",
      "journal-title": "Oncogene.",
      "key": "24_CR17",
      "unstructured": "Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, et al. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene. 2004;24:1477–80.",
      "volume": "24",
      "year": "2004"
    },
    {
      "DOI": "10.1111/j.1349-7006.2010.01711.x",
      "author": "T Mukohara",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Cancer Sci.",
      "key": "24_CR18",
      "unstructured": "Mukohara T. Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer. Cancer Sci. 2011;102:1–8.",
      "volume": "102",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1755-0998.2011.03024.x",
      "author": "TC Glenn",
      "doi-asserted-by": "publisher",
      "first-page": "759",
      "journal-title": "Mol Ecol Resour.",
      "key": "24_CR19",
      "unstructured": "Glenn TC. Field guide to next-generation DNA sequencers. Mol Ecol Resour. 2011;11:759–69.",
      "volume": "11",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nature09534",
      "author": "GP Consortium",
      "doi-asserted-by": "publisher",
      "first-page": "1061",
      "journal-title": "Nature.",
      "key": "24_CR20",
      "unstructured": "Consortium GP. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061–73.",
      "volume": "467",
      "year": "2010"
    },
    {
      "key": "24_CR21",
      "unstructured": "Server EV: NHLBI Go Exome Sequencing Project (ESP). Seattle, WA http://evs.gs.washington.edu/EVS/ 2013:[March 19 Accessed]."
    },
    {
      "DOI": "10.1038/sj.bjc.6601894",
      "author": "S Bamford",
      "doi-asserted-by": "crossref",
      "first-page": "355",
      "journal-title": "Br J Cancer.",
      "key": "24_CR22",
      "unstructured": "Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer. 2004;91:355–8.",
      "volume": "91",
      "year": "2004"
    },
    {
      "DOI": "10.1002/prot.22265",
      "author": "PK Mankoo",
      "doi-asserted-by": "publisher",
      "first-page": "499",
      "journal-title": "Proteins Struc Funct Bioinformatics.",
      "key": "24_CR23",
      "unstructured": "Mankoo PK, Sukumar S, Karchin R. PIK3CA somatic mutations in breast cancer: mechanistic insights from Langevin dynamics simulations. Proteins Struc Funct Bioinformatics. 2009;75:499–508.",
      "volume": "75",
      "year": "2009"
    },
    {
      "DOI": "10.4161/cbt.3.8.994",
      "author": "KE Bachman",
      "doi-asserted-by": "publisher",
      "first-page": "772",
      "journal-title": "Cancer Biol Ther.",
      "key": "24_CR24",
      "unstructured": "Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S, et al. The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther. 2004;3:772–5.",
      "volume": "3",
      "year": "2004"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-09-0632",
      "author": "K Kalinsky",
      "doi-asserted-by": "publisher",
      "first-page": "5049",
      "journal-title": "Clin Cancer Res.",
      "key": "24_CR25",
      "unstructured": "Kalinsky K, Jacks LM, Heguy A, Patil S, Drobnjak M, Bhanot UK, et al. PIK3CA mutation associates with improved outcome in breast cancer. Clin Cancer Res. 2009;15:5049–59.",
      "volume": "15",
      "year": "2009"
    },
    {
      "DOI": "10.1073/pnas.0701005104",
      "author": "M Gymnopoulos",
      "doi-asserted-by": "publisher",
      "first-page": "5569",
      "journal-title": "Proc Natl Acad Sci.",
      "key": "24_CR26",
      "unstructured": "Gymnopoulos M, Elsliger M-A, Vogt PK. Rare cancer-specific mutations in PIK3CA show gain of function. Proc Natl Acad Sci. 2007;104:5569–74.",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.1172/JCI37539",
      "author": "F Di Nicolantonio",
      "doi-asserted-by": "publisher",
      "first-page": "2858",
      "journal-title": "J Clin Invest.",
      "key": "24_CR27",
      "unstructured": "Di Nicolantonio F, Arena S, Tabernero J, Grosso S, Molinari F, Macarulla T, et al. Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. J Clin Invest. 2010;120:2858–66.",
      "volume": "120",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nrd2924",
      "author": "MB Atkins",
      "doi-asserted-by": "publisher",
      "first-page": "535",
      "journal-title": "Nat Rev Drug Discov.",
      "key": "24_CR28",
      "unstructured": "Atkins MB, Yasothan U, Kirkpatrick P. Everolimus. Nat Rev Drug Discov. 2009;8:535–6.",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMoa1109653",
      "author": "J Baselga",
      "doi-asserted-by": "publisher",
      "first-page": "520",
      "journal-title": "N Engl J Med.",
      "key": "24_CR29",
      "unstructured": "Baselga J, Campone M, Piccart M, Burris HA, Rugo HS, Sahmoud T, et al. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med. 2012;366:520–9.",
      "volume": "366",
      "year": "2012"
    },
    {
      "DOI": "10.1245/s10434-007-9751-7",
      "author": "Y-L Lai",
      "doi-asserted-by": "publisher",
      "first-page": "1064",
      "journal-title": "Ann Surg Oncol.",
      "key": "24_CR30",
      "unstructured": "Lai Y-L, Mau B-L, Cheng W-H, Chen H-M, Chiu H-H, Tzen C-Y. PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients. Ann Surg Oncol. 2008;15:1064–9.",
      "volume": "15",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ncponc0509",
      "author": "R Nahta",
      "doi-asserted-by": "publisher",
      "first-page": "269",
      "journal-title": "Nat Clin Prac Oncol.",
      "key": "24_CR31",
      "unstructured": "Nahta R, Yu D, Hung M-C, Hortobagyi GN, Esteva FJ. Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat Clin Prac Oncol. 2006;3:269–80.",
      "volume": "3",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s10549-011-1572-5",
      "author": "E Razis",
      "doi-asserted-by": "publisher",
      "first-page": "447",
      "journal-title": "Breast Cancer Res Treat.",
      "key": "24_CR32",
      "unstructured": "Razis E, Bobos M, Kotoula V, Eleftheraki AG, Kalofonos HP, Pavlakis K, et al. Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer. Breast Cancer Res Treat. 2011;128:447–56.",
      "volume": "128",
      "year": "2011"
    },
    {
      "author": "B Powell",
      "first-page": "443",
      "journal-title": "Clin Cancer Res.",
      "key": "24_CR33",
      "unstructured": "Powell B, Soong R, Iacopetta B, Seshadri R, Smith DR. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Clin Cancer Res. 2000;6:443–51.",
      "volume": "6",
      "year": "2000"
    },
    {
      "DOI": "10.1038/bjc.1993.383",
      "author": "TI Andersen",
      "doi-asserted-by": "publisher",
      "first-page": "540",
      "journal-title": "Br J Cancer.",
      "key": "24_CR34",
      "unstructured": "Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Borresen AL. Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer. 1993;68:540–8.",
      "volume": "68",
      "year": "1993"
    },
    {
      "DOI": "10.1002/(SICI)1097-0215(19971219)74:6\u003c642::AID-IJC15\u003e3.0.CO;2-7",
      "author": "R Soong",
      "doi-asserted-by": "publisher",
      "first-page": "642",
      "journal-title": "Int J Cancer.",
      "key": "24_CR35",
      "unstructured": "Soong R, Iacopetta BJ, Harvey JM, Sterrett GF, Dawkins HJS, Hahnel R, et al. Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer. Int J Cancer. 1997;74:642–7.",
      "volume": "74",
      "year": "1997"
    },
    {
      "DOI": "10.1038/bjc.1998.187",
      "author": "EM Berns",
      "doi-asserted-by": "publisher",
      "first-page": "1130",
      "journal-title": "Br J Cancer.",
      "key": "24_CR36",
      "unstructured": "Berns EM, van Staveren IL, Look MP, Smid M, Klijn JG, Foekens JA. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer. Br J Cancer. 1998;77:1130–6.",
      "volume": "77",
      "year": "1998"
    },
    {
      "author": "M Cuny",
      "first-page": "1077",
      "journal-title": "Cancer Res.",
      "key": "24_CR37",
      "unstructured": "Cuny M, Kramar A, Courjal F, Johannsdottir V, Iacopetta B, Fontaine H, et al. Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations. Cancer Res. 2000;60:1077–83.",
      "volume": "60",
      "year": "2000"
    },
    {
      "author": "S Geisler",
      "first-page": "2505",
      "journal-title": "Cancer Res.",
      "key": "24_CR38",
      "unstructured": "Geisler S, Lonning PE, Aas T, Johnsen H, Fluge O, Haugen DF, et al. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Cancer Res. 2001;61:2505–12.",
      "volume": "61",
      "year": "2001"
    },
    {
      "author": "S Geisler",
      "first-page": "5582",
      "journal-title": "Clin Cancer Res.",
      "key": "24_CR39",
      "unstructured": "Geisler S, Borresen-Dale AL, Johnsen H, Aas T, Geisler J, Akslen LA, et al. TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer. Clin Cancer Res. 2003;9:5582–8.",
      "volume": "9",
      "year": "2003"
    },
    {
      "DOI": "10.1053/hupa.2002.124721",
      "author": "S Bose",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Hum Pathol.",
      "key": "24_CR40",
      "unstructured": "Bose S, Crane A, Hibshoosh H, Mansukhani M, Sandweis L, Parsons R. Reduced expression of PTEN correlates with breast cancer progression. Hum Pathol. 2002;33:405–9.",
      "volume": "33",
      "year": "2002"
    },
    {
      "DOI": "10.1038/modpathol.3880371",
      "author": "PL Depowski",
      "doi-asserted-by": "publisher",
      "first-page": "672",
      "journal-title": "Mod Pathol.",
      "key": "24_CR41",
      "unstructured": "Depowski PL, Rosenthal SI, Ross JS. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod Pathol. 2001;14:672–6.",
      "volume": "14",
      "year": "2001"
    },
    {
      "DOI": "10.1158/0008-5472-CAN-04-3913",
      "author": "LH Saal",
      "doi-asserted-by": "publisher",
      "first-page": "2554",
      "journal-title": "Cancer Res.",
      "key": "24_CR42",
      "unstructured": "Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res. 2005;65:2554–9.",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1002/ijc.27529",
      "author": "N Kim",
      "doi-asserted-by": "publisher",
      "first-page": "2456",
      "journal-title": "Int J Cancer.",
      "key": "24_CR43",
      "unstructured": "Kim N, He N, Kim C, Zhang F, Lu Y, Yu Q, et al. Systematic analysis of genotype-specific drug responses in cancer. Int J Cancer. 2012;131:2456–64.",
      "volume": "131",
      "year": "2012"
    },
    {
      "DOI": "10.1186/gb-2013-14-10-r110",
      "author": "A Daemen",
      "doi-asserted-by": "publisher",
      "first-page": "R110",
      "journal-title": "Genome Biol.",
      "key": "24_CR44",
      "unstructured": "Daemen A, Griffith OL, Heiser LM, Wang NJ, Enache OM, Sanborn Z, et al. Modeling precision treatment of breast cancer. Genome Biol. 2013;14:R110.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1186/bcr3391",
      "author": "SA Moestue",
      "doi-asserted-by": "publisher",
      "first-page": "R16",
      "journal-title": "Breast Cancer Res.",
      "key": "24_CR45",
      "unstructured": "Moestue SA, Dam CG, Gorad SS, Kristian A, Bofin A, Maelandsmo GM, et al. Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Res. 2013;15:R16.",
      "volume": "15",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nature00766",
      "author": "H Davies",
      "doi-asserted-by": "publisher",
      "first-page": "949",
      "journal-title": "Nature.",
      "key": "24_CR46",
      "unstructured": "Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–54.",
      "volume": "417",
      "year": "2002"
    },
    {
      "DOI": "10.1186/1471-2407-14-13",
      "author": "MA Ihle",
      "doi-asserted-by": "publisher",
      "first-page": "13",
      "journal-title": "BMC Cancer.",
      "key": "24_CR47",
      "unstructured": "Ihle MA, Fassunke J, Konig K, Grunewald I, Schlaak M, Kreuzberg N, et al. Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations. BMC Cancer. 2014;14:13.",
      "volume": "14",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10549-012-2035-3",
      "author": "L Santarpia",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "journal-title": "Breast Cancer Res Treat.",
      "key": "24_CR48",
      "unstructured": "Santarpia L, Qi Y, Stemke-Hale K, Wang B, Young EJ, Booser DJ, et al. Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers. Breast Cancer Res Treat. 2012;134:333–43.",
      "volume": "134",
      "year": "2012"
    },
    {
      "DOI": "10.1593/neo.13804",
      "author": "TS Nagaria",
      "doi-asserted-by": "crossref",
      "first-page": "939",
      "journal-title": "Neoplasia.",
      "key": "24_CR49",
      "unstructured": "Nagaria TS, Williams JL, Leduc C, Squire JA, Greer PA, Sangrar W. Flavopiridol synergizes with sorafenib to induce cytotoxicity and potentiate antitumorigenic activity in EGFR/HER-2 and mutant RAS/RAF breast cancer model systems. Neoplasia. 2013;15:939–51.",
      "volume": "15",
      "year": "2013"
    },
    {
      "DOI": "10.1002/humu.20937",
      "author": "FE Bleeker",
      "doi-asserted-by": "publisher",
      "first-page": "7",
      "journal-title": "Hum Mutat.",
      "key": "24_CR50",
      "unstructured": "Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP, et al. IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat. 2009;30:7–11.",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nrm2438",
      "author": "AE Karnoub",
      "doi-asserted-by": "publisher",
      "first-page": "517",
      "journal-title": "Nat Rev Mol Cell Biol.",
      "key": "24_CR51",
      "unstructured": "Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol. 2008;9:517–31.",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.canep.2012.01.004",
      "author": "N Lv",
      "doi-asserted-by": "publisher",
      "first-page": "341",
      "journal-title": "Cancer Epidemiol.",
      "key": "24_CR52",
      "unstructured": "Lv N, Lin S, Xie Z, Tang J, Ge Q, Wu M, et al. Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer. Cancer Epidemiol. 2012;36:341–6.",
      "volume": "36",
      "year": "2012"
    },
    {
      "DOI": "10.1056/NEJMoa064320",
      "author": "CE Geyer",
      "doi-asserted-by": "publisher",
      "first-page": "2733",
      "journal-title": "N Engl J Med.",
      "key": "24_CR53",
      "unstructured": "Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med. 2006;355:2733–43.",
      "volume": "355",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nbt.2198",
      "author": "NJ Loman",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "journal-title": "Nat Biotech.",
      "key": "24_CR54",
      "unstructured": "Loman NJ, Misra RV, Dallman TJ, Constantinidou C, Gharbia SE, Wain J, et al. Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotech. 2012;30:434–9.",
      "volume": "30",
      "year": "2012"
    }
  ],
  "reference-count": 54,
  "references-count": 54,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-015-0024-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "9"
}